Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

Published:2020-12 Issue: Volume:141 Page:9-20
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hulshof Emma C.^ORCID,Deenen Maarten J.^ORCID,Guchelaar Henk-Jan,Gelderblom Hans^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference71 articles.

1. CPT-11 in the treatment of colorectal cancer: clinical efficacy and safety profile;Rougier;Semin Oncol,1996

2. Efficacy and toxicity of irinotecan in patients with colorectal cancer;Rothenberg;Semin Oncol,1998

3. Pharmacogenomics knowledge for personalized medicine;Whirl-Carrillo;Clin Pharmacol Ther,2012

4. Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study;Crona;Pharmacogenomics J,2015

5. UGT1A1∗6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients;Onoue;Int J Clin Oncol,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UGT1A1*28 detection using high-resolution agarose gel electrophoresis;Heliyon;2024-05

2. UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?;Critical Reviews in Oncology/Hematology;2024-04

3. Individual Irinotecan Therapy Under the Guidance of Pre-Treated UGT1A1*6 Genotyping in Gastric Cancer;Technology in Cancer Research & Treatment;2024-01

4. Comment on: Carboplatin and irinotecan (CI) vs. Carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial;Lung Cancer;2023-12

5. Personalizing adjuvant therapy for patients with colorectal cancer;Nature Reviews Clinical Oncology;2023-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3